Not finding it? Sign in to also search OpenAlex live.
-
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry2021 World Allergy Organization Journal article Medicine Coagulation, Bradykinin, Polyphosphates, and Angioedema Open access cited by 2 patents
Anna D. Valerieva, Maria Toncheva Staevska, Vesna Grivcheva‐Panovska, Miloš Jeseňák, Kinga Viktória Kőhalmi, Katarína Hrubišková, +5 more
13citations -
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial2021 Trials article Medicine Traumatic Brain Injury and Neurovascular Disturbances Open access cited by 1 patent
Inge A. M. van Erp, Thomas Arjan van Essen, Kees Fluiter, Erik W. van Zwet, Frank F. Baas, Iain Haitsma, +6 more
9citations -
Plasma-derived and recombinant C1 esterase inhibitor: Binding profiles and neuroprotective properties in brain ischemia/reperfusion injury2021 Brain Behavior and Immunity article Immunology and Microbiology Complement system in diseases Open access
Domenico Mercurio, Arianna Piotti, Alessia Valente, Marco Oggioni, Yolanda Ponstein, Edwin V Amersfoort, +3 more
18citations -
Recombinant Human C1 Esterase Inhibitor Treatment in Addition to Standard of Care for the Prevention of Cytokine Storm in Hospitalized Patients with COVID-19: A Randomized, Open-Label Trial
Bruno Giannetti, Jin P. Guo, Ashraf Raslan, Jürgen Schaale, Michael Bulitta, Anurag Relan, +1 more
0citations -
EE681 Costs of Treating Acute Hereditary Angioedema (HAE) Attacks With C1 Inhibitors in Five Central and Eastern European Countries2022 Value in Health conference-abstract Medicine Coagulation, Bradykinin, Polyphosphates, and Angioedema Open access
JB Tutein Nolthenius, JD Whalen, S Wood, Raphael Coelho Figueiredo
0citations -
EE39 Costs of Treating Hereditary Angioedema (HAE) Attacks with C1 Inhibitors in Four European Countries2022 Value in Health conference-abstract Medicine Coagulation, Bradykinin, Polyphosphates, and Angioedema Open access
JB Tutein Nolthenius, Raphael Coelho Figueiredo, S Wood, JD Whalen
0citations -
Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use2021 Pharmaceuticals article Biochemistry, Genetics and Molecular Biology Viral Infectious Diseases and Gene Expression in Insects Open access
Sacha Sergio Zeerleder, Ruchira Engel, Tao Zhang, Dorina Roem, Gerard van Mierlo, Ineke Wagenaar-Bos, +3 more
3citations -
Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus2024 European Journal of Immunology article Medicine Systemic Lupus Erythematosus Research Open access
Stef van der Meulen, Rory Caitlin Monahan, Kyra A. Gelderman, Cees van Kooten, Y K Onno Teng, Tom W. J. Huizinga, +2 more
3citations -
Intrinsic pathway activation in patients with antiphospholipid syndrome and healthy controls2025 Research and Practice in Thrombosis and Haemostasis article Medicine Systemic Lupus Erythematosus Research Open access
Dagmar J. M. van Mourik, Valérie L. B. I. Jansen, Michiel Coppens, Saskia Middeldorp, Hugo Ten Cate, Harry Roger Buller, +3 more
0citations -
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System2020 Frontiers in Immunology article Medicine COVID-19 Clinical Research Studies Open access cited by 3 patents
Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar Heijnen, Melanie Rudin, Gregor Sommer, +5 more
85citations -
Tackling the Root Cause of Surface‐Induced Coagulation: Inhibition of FXII Activation to Mitigate Coagulation Propagation and Prevent Clotting2023 Macromolecular Bioscience article Materials Science Polymer Surface Interaction Studies Open access
Lena Witzdam, Berlind Vosberg, Katharina Große‐Berkenbusch, Sandra Stoppelkamp, Hans Peter Wendel, César Rodriguez‐Emmenegger
6citations -
Targeted donor complement blockade after brain death prevents delayed graft function in a nonhuman primate model of kidney transplantation2020 American Journal of Transplantation article Medicine Renal Transplantation Outcomes and Treatments Open access cited by 1 patent
Juan Sebastian Danobeitia, Tiffany J. Zens, Peter J. Chlebeck, Laura Jo Zitur, José Antonio Muñoz Reyes, Michael J. Eerhart, +16 more
31citations -
Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis2020 Respiratory Research article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access cited by 1 patent
Sarah Rank Rønnow, Rand Qais Dabbagh, Federica Genovese, Carmel B. Nanthakumar, Vikki Barrett, Robert B. Good, +7 more
48citations -
Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.
Hans A. J. Gelderblom, Mathilde Jalving, Ingrid M.E. Desar, Omar Saavedra, Jourik A. Gietema, Stefan G. van Ravensteijn, +7 more
16citations -
Dysregulated complement activation in COVID-19: The Role of Soluble Complement Inhibitors2026 Clinical & Experimental Immunology article Immunology and Microbiology Complement system in diseases Open access
Stef van der Meulen, Haiyu Wang, Sandrine Nugteren, Frédérique Ponchel, Anna H.E. Roukens, Cilia R. Pothast, +45 more
0citations -
Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid
Jenny Giang, Martijn B. A. van Doorn, Gilles F.H. Diercks, Santiago Rodrı́guez de Córdoba, Thierry P. P. van den Bosch, Marco W.J. Schreurs, +2 more
3citations -
POS1123 IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY
Maxime Dougados, A. Lardy-Cléaud, E. Desfleurs, Pascal Claudepierre, Philippe Goupille, A. Ruyssen-Witrand, +4 more
1citations -
Patient reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after imatinib treatment in INTRIGUE: A phase 3 open-label study.2022 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment Open access
Hans A. J. Gelderblom, Robin L. Jones, Jean‐Yves Blay, Suzanne George, Patrick Schöffski, Margaret von Mehren, +13 more
3citations